News from AIDS 2014

The 20th International AIDS Conference (AIDS 2014) is taking place in Melbourne, Australia, 20-25th July 2014.

Our writers will be reporting on key research presented at the conference, publishing news and sending out news summary bulletins by email.

“The coverage made me feel I was at the conference and I appreciate NAM's effort in sharing the bulletins.” NAM bulletin subscriber

aidsmap news from AIDS 2014

AbbVie 3D regimen cures most genotype 1 HCV in people with HIV and HCV co-infection

An oral regimen of three direct-acting antivirals plus ribavirin taken for 12 weeks demonstrated a sustained virological response rate of 94% for people with both HIV and

Published
21 July 2014
By
Liz Highleyman
Sofosbuvir + ribavirin cures hepatitis C for more than 80% of people with HIV and HCV co-infection

An interferon-free regimen of sofosbuvir (Sovaldi) plus ribavirin for 24 weeks led to sustained hepatitis C virological response in 84 to 89% of HIV-positive people with chronic

Published
21 July 2014
By
Liz Highleyman
Recession and income inequality have fuelled HIV infections in European drug users

In European countries, increases in rates of reported HIV infections among people who inject drugs in recent years have been associated with the economic downturn and income

Published
21 July 2014
By
Roger Pebody
AIDS 2014 opening ceremony honours Flight MH17 dead with drive to end AIDS by 2030

The 20th International AIDS Conference (AIDS 2014) opened in Melbourne, Australia, on Sunday evening overshadowed by the deaths of 298 passengers aboard Malaysian Airlines flight MH17. Six delegates

Published
20 July 2014
By
Keith Alcorn
← Prev12345Next →

Email bulletins

Sign up for conference news bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

NAM’s AIDS 2014 bulletins have been made possible thanks to support from Bristol-Myers Squibb. NAM's wider conference news reporting services have been supported by AbbVie, Gilead Sciences, Janssen and ViiV Healthcare’s Positive Action Programme.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.